BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11380524)

  • 1. A proteasome inhibitor prevents vascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Takaoka M; Ohkita M; Itoh M; Kobayashi Y; Okamoto H; Matsumura Y
    Clin Exp Pharmacol Physiol; 2001; 28(5-6):466-8. PubMed ID: 11380524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
    Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A proteasome inhibitor lessens the increased aortic endothelin-1 content in deoxycorticosterone acetate-salt hypertensive rats.
    Okamoto H; Takaoka M; Ohkita M; Itoh M; Nishioka M; Matsumura Y
    Eur J Pharmacol; 1998 May; 350(1):R11-2. PubMed ID: 9683028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive effect of a proteasome inhibitor in DOCA-salt hypertensive rats.
    Takaoka M; Okamoto H; Ito M; Nishioka M; Kita S; Matsumura Y
    Life Sci; 1998; 63(4):PL65-70. PubMed ID: 9698041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
    Matsumura Y; Fujita K; Miyazaki Y; Takaoka M; Morimoto S
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S456-8. PubMed ID: 8587444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
    Kawanishi H; Hasegawa Y; Nakano D; Ohkita M; Takaoka M; Ohno Y; Matsumura Y
    Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):280-5. PubMed ID: 17324138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of the endothelin-1 gene in blood vessels of DOCA-salt hypertensive rats: correlation with vascular structure.
    Schiffrin EL; Larivière R; Li JS; Sventek P
    J Vasc Res; 1996; 33(3):235-48. PubMed ID: 8924521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats.
    Day R; Larivière R; Schiffrin EL
    Am J Hypertens; 1995 Mar; 8(3):294-300. PubMed ID: 7794580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
    Schiffrin EL; Lariviere R; Li JS; Sventek P; Touyz RM
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-carnitine attenuates cardiac remodelling rather than vascular remodelling in deoxycorticosterone acetate-salt hypertensive rats.
    O'Brien D; Chunduri P; Iyer A; Brown L
    Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):296-301. PubMed ID: 20041879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the endothelin ETA-receptor antagonist FR139317 on development of hypertension and cardiovascular hypertrophy in deoxycorticosterone acetate-salt hypertensive rats.
    Fujita K; Matsumura Y; Miyazaki Y; Takaoka M; Morimoto S
    Jpn J Pharmacol; 1996 Apr; 70(4):313-9. PubMed ID: 8774759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of SA7060, a novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Kuro T; Okahara A; Nose M; Ikuse T; Matsumura Y
    Biol Pharm Bull; 2000 Jul; 23(7):820-5. PubMed ID: 10919359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular and cardiac overexpression of endothelin-1 gene in one-kidney, one clip Goldblatt hypertensive rats but only in the late phase of two-kidney one clip Goldblatt hypertension.
    Sventek P; Turgeon A; García R; Schiffrin EL
    J Hypertens; 1996 Jan; 14(1):57-64. PubMed ID: 12013496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
    Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase.
    Jiménez R; López-Sepúlveda R; Kadmiri M; Romero M; Vera R; Sánchez M; Vargas F; O'Valle F; Zarzuelo A; Dueñas M; Santos-Buelga C; Duarte J
    Free Radic Biol Med; 2007 Aug; 43(3):462-73. PubMed ID: 17602962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dietary calcium on the development of hypertension and hypertensive vascular lesions in DOCA-salt and two-kidney, one clip hypertensive rats.
    Liu DT; Birchall I; Hewitson T; Kincaid-Smith P; Whitworth JA
    J Hypertens; 1994 Feb; 12(2):145-53. PubMed ID: 8021465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered cardiac endothelin receptors and protein kinase C in deoxycorticosterone-salt hypertensive rats.
    Fareh J; Touyz RM; Schiffrin EL; Thibault G
    J Mol Cell Cardiol; 2000 Apr; 32(4):665-76. PubMed ID: 10756122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats.
    Jin L; Beswick RA; Yamamoto T; Palmer T; Taylor TA; Pollock JS; Pollock DM; Brands MW; Webb RC
    J Physiol Pharmacol; 2006 Sep; 57(3):343-57. PubMed ID: 17033089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.